Literature DB >> 34700233

Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies.

Mahshid Deldar Abad Paskeh1, Sepideh Mirzaei2, Mohammad Hossein Gholami3, Ali Zarrabi4, Amirhossein Zabolian5, Mehrdad Hashemi1, Kiavash Hushmandi6, Milad Ashrafizadeh7, Amir Reza Aref8, Saeed Samarghandian9.   

Abstract

Cervical cancer is the fourth common gynecologic cancer and is considered as second leading cause of death among women. Various strategies are applied in treatment of cervical cancer including radiotherapy, chemotherapy and surgery. However, cervical cancer cells demonstrate aggressive behavior in advanced phases, requiring novel strategies in their elimination. On the other hand, SOX proteins are transcription factors capable of regulating different molecular pathways and their expression varies during embryogenesis, disease development and carcinogenesis. In the present review, our aim is to reveal role of SOX transcription factors in cervical cancer. SOX transcription factors play like a double-edged sword in cancer. For instance, SOX9 possesses both tumor-suppressor and tumor-promoting role in cervical cancer. Therefore, exact role of each SOX members in cervical cancer has been discussed to direct further experiments for revealing other functions. SOX proteins can regulate proliferation and metastasis of cervical cancer cells. Furthermore, response of cervical cancer cells to chemotherapy and radiotherapy is tightly regulated by SOX transcription factors. Different downstream targets of SOX proteins such as Wnt signaling, EMT and Hedgehog have been identified. Besides, upstream mediators such as microRNAs, lncRNAs and circRNAs can regulate SOX expression in cervical cancer. In addition to pre-clinical studies, role of SOX transcription factors as prognostic and diagnostic tools in cervical cancer has been shown.
Copyright © 2021. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Biomarker; Cancer therapy; Cervical cancer; Chemoresistance; Non-coding RNAs; SOX transcription factor

Mesh:

Substances:

Year:  2021        PMID: 34700233     DOI: 10.1016/j.biopha.2021.112335

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer.

Authors:  Marzieh Ramezani Farani; Maryam Azarian; Hamid Heydari Sheikh Hossein; Zohreh Abdolvahabi; Zahra Mohammadi Abgarmi; Arash Moradi; Seyyedeh Maedeh Mousavi; Milad Ashrafizadeh; Pooyan Makvandi; Mohammad Reza Saeb; Navid Rabiee
Journal:  ACS Appl Bio Mater       Date:  2022-02-24

2.  The Dysregulation of SOX Family Correlates with DNA Methylation and Immune Microenvironment Characteristics to Predict Prognosis in Hepatocellular Carcinoma.

Authors:  Sha Qin; Gaoming Liu; Haoer Jin; Xue Chen; Jiang He; Juxiong Xiao; Yan Qin; Yitao Mao; Luqing Zhao
Journal:  Dis Markers       Date:  2022-04-13       Impact factor: 3.464

Review 3.  Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies.

Authors:  Daniel L Pouliquen; Alice Boissard; Cécile Henry; Olivier Coqueret; Catherine Guette
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

4.  Prognostic value of SOX9 in cervical cancer: Bioinformatics and experimental approaches.

Authors:  Huan Chen; Xupeng Chen; Fanhua Zeng; Aizhen Fu; Meiyuan Huang
Journal:  Front Genet       Date:  2022-08-08       Impact factor: 4.772

5.  A highly efficient polydopamine encapsulated clinical ICG theranostic nanoplatform for enhanced photothermal therapy of cervical cancer.

Authors:  Zhong Du; Rong Ma; Shuang Chen; Huimin Fan; Youqiang Heng; Ting Yan; Gulinigaer Alimu; Lijun Zhu; Xueliang Zhang; Nuernisha Alifu; Cailing Ma
Journal:  Nanoscale Adv       Date:  2022-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.